プロモーションスケジュール Amarin
詳細なスケジュール
簡易グラフ
会社について
Amarin Corporation — биофармацевтическая компания, основанная в 1993 году. Основана в 1993, располагается в Бедминстере, Нью-Джерс, США. Разрабатывает лекарства для лечения кардиоваскулярных заболеваний.Лекарство: https://www.vascepa.com/
https://finance.yahoo.com/quote/AMRN/profile?p=AMRN
https://www.bloomberg.com/quote/AMRN:US
| Цена ао | 1.56 |
|---|---|
| P/E | 177.57 |
| P/S | 16.7 |
| P/BV | 11.8 |
| EV/EBITDA | -415.71 |
| Дивиденд ао | |
| Див.доход ао | |
| EBITDA | -0.0159 |
| Сайт | http://www.amarincorp.com |
| Число акций ао | 0.40766 млрд |
| Выручка | 0.4298 |
| ISIN | US0231112063 |
| Валюта | usd |
| IPO date | 1993-04-01 |
| Sector | Health Care |
| Industry | Biotechnology |
| Валюта отчета | usd |
| 1日あたりの価格変動: | 0% (0.529) |
|---|---|
| 週ごとの価格変動: | +7.81% (0.4907) |
| 月ごとの料金変更: | -9.12% (0.5821) |
| 3ヶ月間の価格変動: | -13.9% (0.6144) |
| 半年間の価格変動: | -37.05% (0.8403) |
| 年間の価格変動: | -28.51% (0.74) |
| 3年間の価格推移: | -83.26% (3.16) |
| 5年間の価格推移: | -92.48% (7.03) |
| 10年間の価格推移: | -72.16% (1.9) |
| 年初からの価格変動: | -40.56% (0.89) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| 機関 | 音量 | 共有, % |
|---|---|---|
| Sarissa Capital Management, LP | 24850623 | 25.15 |
| Kynam Capital Management, LP | 12022957 | 12.17 |
| Eversept Partners, LP | 6095505 | 6.17 |
| Morgan Stanley | 5563083 | 5.63 |
| DG Capital Management, LLC | 5405438 | 5.47 |
| Two Sigma Investments, LP | 3184293 | 3.22 |
| Tang Capital Management, LLC | 3086544 | 3.12 |
| Two Sigma Advisers, LP | 2727602 | 2.76 |
| Millennium Management LLC | 2538596 | 2.57 |
| SCP Investment, LP | 2500000 | 2.53 |
| ETF | 共有, % | 年間の利益率, % | 配当金, % |
|---|---|---|---|
| ProShares Ultra Nasdaq Biotechnology | 0.01596 | 51.697637072723 | 0.85651 |
| ProShares UltraShort Nasdaq Biotechnology | 0.85 | -40.363937138131 | 1.76 |
| SPDR S&P International Small Cap ETF | 0.01199 | 8.9378151260504 | 3.10348 |
| Invesco Nasdaq Biotechnology ETF | 0.02306 | 28.578975171685 | 0.8565 |
| SPDR Portfolio Developed World ex-US ETF | 0.00069 | 12.213976499691 | 3.28401 |
| Principal Healthcare Innovators ETF | 0.02403 | 618.4964157054 | 0.8416 |
| Future Tech ETF | 0.02403 | 426.33969118983 | 0.8416 |
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Mr. Aaron D. Berg | CEO & President | 1.26M | 1963 (61 年) |
| Dr. Steven B. Ketchum Ph.D. | Executive VP, President of Research & Development and Chief Scientific Officer | 1.16M | 1965 (59 年) |
| Mr. Jordan Zwick | Senior VP of Corporate Business Development & Investor Relations | N/A | 1987 (37 年) |
| Dr. David Keenan Ph.D. | Executive VP of Technical Operations & President of Europe | N/A | |
| Mr. Laurent Abuaf | President of Europe & Senior VP | N/A | |
| Dr. Nabil Abadir | Chief Medical Officer of Global Medical Affairs | N/A | |
| Mr. Jonathan N. Provoost | Executive VP, Chief Legal & Compliance Officer and Secretary | 160.08k | 1970 (54 年) |
| Mr. Thomas Charles Reilly | Executive VP, CFO & Global Head of HR | 1972 (52 年) |
住所: Ireland, Dublin , Grand Canal Docklands - Googleマップで開く, Yandexマップを開く
Webサイト: http://www.amarincorp.com
Webサイト: http://www.amarincorp.com
